The aim of this project is to characterize HIV- and STI-related outcomes in a U.S. national sample of diverse transgender youth ages 16 to 24 years drawn from 14 geographic clinic catchment areas.
National
Eligibility:
Transgender and other gender minority youth ages 16-24 years: 1) currently in HIV care at an Adolescent Medicine Trials Unit (AMTU) site or elsewhere, 2) living with HIV but not currently in care, not living with HIV, or unaware of HIV status
Funder: Aerosmith Endowment Fund for Prevention and Treatment of AIDS and HIV Infection
Dates: 2017-2019, not currently recruiting
PI: Sari Reisner